4.2 Review

Optimizing the engagement of care cascade: a critical step to maximize the impact of HIV treatment as prevention

Journal

CURRENT OPINION IN HIV AND AIDS
Volume 7, Issue 6, Pages 579-586

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/COH.0b013e3283590617

Keywords

HIV care cascade; linkage to care; test and treat; treatment as prevention

Funding

  1. British Columbia Ministry or Health from National Institute of Drug Abuse (NIDA), at the US National Institutes of Health (NIH) [1DP1DA026182]
  2. Canadian Institutes of Health Research (CIHR)
  3. International AIDS Society
  4. United Nations AIDS Program
  5. World Health Organization
  6. National Institutes of Health Research-Office of AIDS Research
  7. National Institute of Allergy & Infectious Diseases
  8. United States President's Emergency Plan for AIDS Relief (PEPfAR)
  9. Bill & Melinda Gates Foundation
  10. French National Agency for Research on AIDS & Viral Hepatitis (ANRS)
  11. Public Health Agency of Canada
  12. University of British Columbia
  13. Simon Fraser University
  14. Providence Healthcare and Vancouver Coastal Health Authority
  15. Abbott
  16. Biolytical
  17. Boehringer-Ingelheim
  18. Bristol-Myers Squibb
  19. Gilead Sciences
  20. Janssen
  21. Merck
  22. ViiV Healthcare
  23. National Institute on Drug Abuse [R01DA031043-01]

Ask authors/readers for more resources

Purpose of review At present, data from mathematical models, ecologic studies and a clinical trial demonstrate that use of combination antiretroviral therapy (cART) can markedly reduce HIV transmission. Expansion of cART uptake (Treatment as Prevention) is a critical component of biomedical interventions to prevent HIV transmission. Recent findings Successful implementation is dependent on identifying undiagnosed individuals, linking and retaining them in care and initiating durable and potent cART regimens. This continuum is encapsulated within the framework of the 'Test and Treat', or 'Seek, Test, Treat and Retain' strategies. Currently only 19-28% of all HIV-infected individuals in the USA are estimated to be virologically suppressed. Summary Optimizing the engagement of care cascade represents a critical step to maximize the individual and societal impact of cART and therefore deliver on the promise of HIV Treatment as Prevention.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available